Elevate Capital Advisors LLC Invests $834,000 in The Clorox Company (NYSE:CLX)

Elevate Capital Advisors LLC purchased a new stake in shares of The Clorox Company (NYSE:CLXFree Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 5,135 shares of the company’s stock, valued at approximately $834,000.

Other institutional investors also recently bought and sold shares of the company. Brooklyn Investment Group increased its holdings in shares of Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares in the last quarter. Prospera Private Wealth LLC acquired a new stake in Clorox during the third quarter valued at $27,000. Continuum Advisory LLC increased its holdings in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after buying an additional 138 shares in the last quarter. Carolina Wealth Advisors LLC acquired a new position in shares of Clorox in the third quarter worth about $48,000. Finally, Friedenthal Financial purchased a new stake in shares of Clorox during the 3rd quarter worth about $49,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on CLX. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Royal Bank of Canada restated a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. DA Davidson decreased their target price on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. Barclays boosted their price target on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a report on Wednesday, February 5th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $158.21.

Get Our Latest Report on CLX

Clorox Trading Up 0.6 %

Shares of Clorox stock opened at $148.51 on Monday. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.62. The stock has a market cap of $18.38 billion, a P/E ratio of 40.58, a P/E/G ratio of 2.52 and a beta of 0.42. The stock’s 50 day simple moving average is $161.06 and its 200-day simple moving average is $158.88.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter last year, the company earned $2.16 EPS. Analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 3.29%. Clorox’s dividend payout ratio (DPR) is 133.33%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.